11/01/2024
2:19 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024
3:13 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
10:38 AM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
1:27 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:39 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/06/2024
5:39 PM | Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:40 PM | Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:40 PM | Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:41 PM | Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:42 PM | Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:42 PM | Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:45 PM | ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:48 PM | Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:50 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:52 PM | Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:53 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:57 PM | Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:29 PM | Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:35 PM | Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:42 PM | Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:49 PM | Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:55 PM | Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:19 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:33 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
7:11 PM | Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2024
3:46 PM | Jazz Pharmaceuticals (Filer)
| Form DEFA14A | |
07/22/2024
6:57 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
7:15 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:31 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:38 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
3:39 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:07 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:49 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:53 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:44 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:47 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:48 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A new way to play the AI boom (act before November 19) (Ad) There's a new way to play the $15 trillion AI boom.
And it's so simple - you can do it right now with as little as $16 and a brokerage account. Click here to get the ticker >>> |
03/07/2024
5:09 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:54 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:58 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:28 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:32 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:34 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:44 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:47 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:50 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:52 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:11 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2024
6:14 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/01/2024
2:11 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
6:46 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
6:29 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/25/2024
4:01 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024
5:19 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:21 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:23 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:25 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:28 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
5:33 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2023
3:39 PM | Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:31 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
